Company Announcements

Environmental recognition for CleanTreat®

Source: RNS
RNS Number : 6825M
Benchmark Holdings PLC
23 September 2021

23 September 2021

Benchmark Holdings plc

("Benchmark" or the "Company")


Environmental recognition for CleanTreat®


Benchmark's CleanTreat® system receives highest recognition for environmental protection

and sustainability from the Aquaculture Stewardship Council

Benchmark Holdings, the aquaculture biotechnology company, is pleased to announce that the Aquaculture Stewardship Council (ASC), the world's leading independent certification scheme for farmed aquaculture, confirmed a score of 'zero' for its cutting-edge CleanTreat® system. ASC plays a vital role in maintaining the strictest environmental and welfare standards in the industry and this is the highest level of recognition that it awards for environmental protection and sustainability.

Following an extensive review, the ASC included CleanTreat® as a mitigation tool in its current 'Weighted Number of Medicinal Treatments'. ASC concluded that any treatments performed in a closed contained system, that then applies water purification steps to remove the veterinary medicine, will receive a score of 'zero' - the best score possible.

This news represents a major milestone for Benchmark and is an encouraging endorsement of its CleanTreat® system. An ASC scoring of 'zero' for Benchmark's CleanTreat® system will support farmers in meeting key ASC criteria, providing a valuable tool, which does not increase the 'Weighted Number of Medicinal Treatments'. Importantly, this allows farmers to use Integrated Pest Management strategies, which are crucial to effective and robust sea lice management. The effective use of Benchmark's CleanTreat® will further enable the sustainable growth of the aquaculture industry whilst protecting the surrounding environment.

CleanTreat® is a cutting-edge water purification system that removes medicines from treatment water before safely returning cleaned water to the sea. CleanTreat® also removes the organic material from treatment water including sea lice, egg strings, fish scales and faecal matter - an essential step in combating parasitic resistance to medicines. Benchmark's Ectosan® Vet treatment, launched in combination with CleanTreat®, received Marketing Authorisation from the Norwegian Medicines Agency in July 2021. The Company's first CleanTreat® unit is currently in operation and its Ectosan® Vet sea lice treatments were commenced for customers during August 2021.

Trond Williksen, CEO, commented:

"Our mission is to drive sustainability in aquaculture and we are delighted to have received the highest recognition possible by the ASC for our CleanTreat® system. We are proud to help farmers and the wider industry take a responsible approach to medicine use and are excited to play a major role in driving sustainability across the industry."




For further information, please contact:

Benchmark Holdings plc

Tel:  020 3696 0630

Trond Williksen, CEO

Septima Maguire, CFO

Ivonne Cantu, Investor Relations

Numis (Broker and NOMAD)

Tel:  020 7260 1000

James Black, Freddie Barnfield, Duncan Monteith


MHP Communications

Tel:  020 3128 8742

Katie Hunt, Reg Hoare, Alistair de Kare-Silver                                  



About Benchmark 

Benchmark is a leading aquaculture biotechnology company. Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.

We bring together biology and technology to develop innovative products and solutions which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), specialist diets and probiotics and sea lice treatments. Find out more at


This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.